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To locate the genes that make a substantial contribu-tion to variation in natural dizygotic twinning in
humans, large-scale studies are needed. New studies
should not stop at DNA genotyping, but collect material
that allow gene-expression analysis, transcriptomics,
proteomics and endocrinology. In this article we
describe a pilot study to examine the feasibility, effec-
tiveness and logistics of large-scale nationwide sample
collection in Dutch families in which two or more
sisters have given birth to spontaneous dizygotic
twins. Pedigree data and addresses from family
members of proband mothers were collected by tele-
phone. Blood and urine samples were collected during
a home visit, and handled in the afternoon. All partici-
pants were bled between 7 a.m. and 10 a.m. after
overnight fasting. Blood samples of fertile women
with a natural cycle were collected on the second,
third or fourth day of their menstrual cycle. The effects
of transportation and storage on blood quality, lipids,
RNA with and without challenge, lymphocytes and
other parameters were examined. Genomic DNA was
isolated from blood and cells were immortalized using
Epstein–Barr virus. In 78.6% of the women with a
natural cycle blood samples were collected on the
second, third or fourth day of the menstrual cycle. This
percentage is likely to increase with the more dense
geographical distribution of participants in the larger
population. We conclude that the pilot study demon-
strated the feasibility of this protocol to collect good
quality of plasma, DNA, RNA and lymphocyte samples
by home visits.
It has been firmly established that variation in dizygotic
(DZ) twinning has a genetic component (Bulmer, 1970).
Family studies found significantly higher frequencies of
DZ twins in female relatives of DZ probands compared
with monozygotic (MZ) probands. Both autosomal
monogenic dominant and recessive models of inheri-
tance have been described (Lewis et al., 1996;
Meulemans et al., 1996). However, the genetic architec-
ture of twinning in humans remains unclear.
There are good animal models of twinning in
mammals, especially in sheep. An important question is
whether natural variation in human twinning is con-
trolled by some of the same mechanisms as have been
identified in sheep, or through other pathways. For
example, mutations in three members (BMP15,
BMPR1B and GDF9) of the intraovarian transforming
growth factor beta (TGFb) signaling pathway increase
the frequency of twins and higher-order multiples, in
sheep (Galloway et al., 2000; Hanrahan et al., 2004;
Wilson et al., 2001). Mutations in BMP15 and GDF9
are associated with both increased ovulation rate and
sterility in Cambridge and Belclare sheep (Hanrahan et
al., 2004). 
One reason for the lack of success so far to identify
the genetic contribution to human DZ twinning may be
the small sample size of many studies. We are therefore
recruiting a large sample of sister pairs who have both
given birth to spontaneous DZ twins. Affected sister
pairs, their parents and other informative family
members will be recruited in the Netherlands, in
Australia and New Zealand. In the Netherlands, 500
families will be identified through the Netherlands Twin
Registry (NTR) and in Australia and New Zealand, 500
families will be recruited through appeals in the media.
The proposed study aims to extend our previous studies
of the endocrinology, epidemiology and molecular
genetics of twinning in humans (Boomsma et al., 1992;
Lambalk et al., 1998; Martin et al., 1984; Martin et al.,
1991; Montgomery et al., 2003). 
The collection of biological material other than
DNA samples that enables the study of the endocrinol-
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ogy of twinning, the identification of candidate genes
through expression studies and possibly the characteri-
zation of affected women through system biology
approaches requires the establishment of large
biobanks. Biobanks can be defined as stored collections
of genetic samples and biological materials from partici-
pants coming from selected groups or from random
populations. Biological materials include genomic DNA,
RNA, lymphocytes serum and/or plasma which enables
investigators to perform long-term genomic, transcrip-
tomic or proteomic studies (Austin et al., 2003; Kaiser,
2002; Nederhand et al., 2003). At the moment, charac-
terization of individuals and families, using these
techniques, including large-scale genotyping of
microsatellites and SNPs, represents a major cost.
Therefore, the aim is to collect multiple phenotypes in
such studies, so that linkage and association analysis can
be conducted for multiple phenotypes within the same
families. To be cost-effective and to minimize the future
burden for participants, a broad range of biomaterials
should be collected in a single visit that allows future
study of multiple (disease) traits and endophenotypes.
Ideally, the multiple phenotypes reflect variation in
physiological parameters, which are related to affec-
tion status, but with appropriate sample collection,
large-scale studies will also provide a valuable resource
for many traits that can be assessed in plasma or
serum. Some of these traits require standardized proto-
cols. For example, to assess lipid levels, glucose and
insulin participants ideally are bled after overnight
fasting and at a fixed time of the day. For other para-
meters, following a certain circadian pattern (such as
cortisol) participants need to be bled at a fixed time of
the day. To study the endocrinology of twinning, blood
samples in fertile women need to be collected around
the time of follicle recruitment.
In this paper, we describe a pilot study to examine
the feasibility, effectiveness and logistics of large-scale
nationwide biomaterials collection in the Netherlands
to locate genes responsible for DZ twinning. We first
describe the procedure for recruitment of families of
affected sister pairs and next of phenotype and bio-
logical sample collection. The logistics of transport
and blood handling and the procedures for blood
handling and results of RNA isolation are described. 
Materials and Methods
Participants
The study was approved by the Central Ethics
Committee on Research Involving Human Subjects of
the Vrije Universiteit (Amsterdam). We approached 24
mothers of dizygotic twins (MODZT) registered with
the Netherlands Twin Registry (NTR). These mothers
reported in survey studies of the NTR having one or
more sisters with a twin or multiple births. Most of
them had responded to an article in the yearly newslet-
ter of the NTR about this study.
The proband mother was contacted by letter, fol-
lowed by a telephone call to collect pedigree data and to
obtain permission to approach her sister, her parents
and/or other siblings. All family members were initially
informed about the study by the proband mother and
after giving their permission to be contacted, were sent a
letter and information brochure about the study. To be
eligible for the study, two or more sisters had to have
given birth to spontaneous dizygotic twins. If one or
both parents were unavailable or deceased, other sib-
lings were asked for their participation. 
To assess hormone levels at the time of follicle
recruitment in fertile women, blood and urine samples
of women with a natural cycle were taken on the
second, third or fourth day of the menstrual cycle. In
women who used oral contraceptives (OC) blood and
urine samples were taken in the week the women did
not take OC pills. All of these women used combination
OCs. Menopausal women, fathers and brothers did not
have to meet these criteria. All participants gave written
informed consent prior to participation in the study.
Interview
Pedigree data about DZ twinning and fertility were
obtained from a telephone interview with the proband
mother and her sister. The interview time was between
20 and 30 minutes. The interview for MODZT con-
sisted of five parts. Part A contained 20 items regarding
age, birth weight, parity and mother’s judgment of
zygosity of the twins. In part B, 11 items about birth
history, use of hormone treatment or IVF in the concep-
tion of the twins and in other conceptions were asked.
Part C asked about family history of twinning and fertil-
ity. Pedigree data were obtained for the family of the
proband mother, for her mother’s family, her father’s
family and for the family of her husband. Part D con-
tained 19 items regarding health and medical history.
Data were collected on height, weight (before, during
and after the twin pregnancy), menstrual cycle,
menopause (of proband and her mother), use of contra-
ception and health problems. The last part of the
questionnaire, part E, contained four items about ances-
try of the parents and grandparents of the MODZT. 
Blood Sampling
Venous blood samples and ‘morning’ urine samples
were taken from the MODZT, their parents and/or
additional siblings between 7.00 a.m. and 10.00 a.m.
and after overnight fasting. A total of seven blood
tubes was collected from all participants for DNA,
lymphocytes, RNA (basal and after dexamethasone
challenge) and plasma. The order of sample draw was
2 × 9 ml EDTA, 3 × 9 ml Heparin, 1 × 4.5 ml citrate
and 1 × 2 ml EDTA. For collection, we used a safety-
lock butterfly needle. With this system, tubes can be
quickly and hygienically changed. To prevent clotting
all tubes were inverted gently 8–10 times immediately
after collection. 
For DNA isolation and EDTA plasma, blood was
collected in 2 × 9 ml EDTA anticoagulant tubes. The
tubes were stored in melting ice (0–2˚C) during trans-
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port. For RNA isolation, we used 2 × 9 ml lithium
heparin coagulant tubes. Within 1 hour after collec-
tion one heparin tube for basal RNA was divided in
3 × 3ml aliquots. The aliquots were snap-frozen in
acetone with dry ice and stored at –80˚C during
transport. Dexamethasone (dex) was added to the
second heparin tube to a final concentration of 10–7
M within 1 hour after collection. During transport
and for exactly 6 hours, the tube was stored in an
insulated box with a constant temperature of 37˚C.
After 6 hours’ incubation the tube was inverted
gently 8–10 times and subsequently divided in 3 × 3
ml aliquots. The aliquots were snap frozen in acetone
with dry ice and stored at –80˚C. 
For future coagulation studies, blood was col-
lected in a 4.5 ml sodium citrate tube, which during
transport was stored in melting ice (0–2˚C). Blood
variables including levels of lipids, apolipoproteins,
HbA1c (haemoglobin A1c: an index of average blood
glucose levels over a 2- to 3-month period) and CRP
(C-reactive protein) were measured in samples col-
lected in a 2 ml EDTA tube, which was stored at
room temperature (RT) during transport (see Table 1
for blood picture overview). Urine samples were col-
lected in 2 × 10 ml vacutainers, and stored in melting
ice during car transport. 
All samples were transported to the laboratory in
Leiden. Average transport time was 4 hours and all
samples were centrifuged within 6 hours after collec-
tion. The degree of haemolysis was determined by
observing the color of the plasma after the centrifuga-
tion step.
The EDTA, citrate tube and the urine samples were
centrifuged 20 minutes at 2000xg 4˚C. EDTA and cit-
rated plasma was harvested from the buffy coat and
red blood cells, aliquoted (0.5 ml), snap-frozen in
acetone and dry ice, and stored at –80˚C. The urine
was decanted carefully into new plastic tubes without
the debris pellet. The EDTA vacutainers with buffy
coat and red cells, and the urine samples were stored at
–20˚C. The heparin vacutainer for lymphocyte isola-
tion was centrifuged for 15 minutes at 1000xg at 4˚C.
After the centrifugation step, heparin plasma was
divided into 8 subsamples of 0.5ml, snap-frozen and
stored at –80˚C. For lymphocyte isolation 14 ml phos-
phate-buffered saline (PBS) was added to the heparin
blood, buffycoat and remaining plasma, then the
diluted blood was added to 10 ml Ficoll. 
This was centrifuged 25 minutes at 800xg at RT.
The lymphocytes were pipetted into a new tube and
45 ml PBS was added. The solution was centrifuged 10
minutes at 250xg RT. This washing step was repeated
after discarding the supernatant. The lymphocyte pellet
was then taken up into 1 ml RPMI: 20% Fetal Calf
Serum (FCS) 10% and dimethyl sulfoxide (DMSO).
Finally, pellets were frozen and stored overnight at
–80˚C and then transferred to liquid nitrogen for long-
term storage. An overview of blood collection,
transport and blood handling is listed in Figure 1. 
To test the viability of frozen lymphocyte pellets
we transfected 8 samples, originating from 4 individu-
als, with Epstein–Barr virus B95–8. Cells were
centrifuged for 10 minutes at 1200 rpm. Supernatant
was removed and the cell pellet washed in 10.5 ml
RPMI with 1% FCS. After a second centrifugation of
10 minutes at 1200 rpm ~106 cells were suspended in
2 ml RPMI plus 15% FCS and 1 mM Na-pyruvate
and PenStrep and co-cultured with EBV virus. After
Table 1
Overview of Traits Assessed in Blood/Plasma in all Participants
Blood variable N Mean SD Range
HbA1c HbA1c (%) 69 5.6 .44 4.5–7.1
CRP CRP (mg/L) 73 5.45 12.10 .14–83.80
Hematocrit Ht (%) 49 40.54 3.54 29.2–52.3
White blood cell counts WBC* 49 6.04 1.65 3.1–11.0
Red blood cell count RBC** 49 4.47 .40 3.83–5.71
Red cell distribution width RDW (%) 48 12.80 1.75 10.9–23.3
Haemoglobin concentration Hb (g/dl) 49 13.31 1.12 10.0–15.8
Mean corpuscular haemoglobin MCH (pg) 49 29.81 1.95 24.5–33.6
Mean corpuscular Hb concentration MCHC (g/dl) 49 32.92 2.04 29.3–43.2
Mean corpuscular volume MCV (fl) 49 90.70 5.51 71.5–99.6
Platelet count TROM* 49 270.49 114.65 73.0–532.0
Mean platelet volume MPV (fl) 49 8.60 .86 7.1–12.6
Total cholesterol TC (mmol/L) 86 5.48 .92 3.46–7.4
Triglycerides TGs (mmol/L) 86 1.26 .52 .48–3.01
High-density lipoprotein HDL (mmol/L) 86 1.70 .51 .54–3.31
Low-density lipoprotein (calculated) LDL (mmol/L) 86 3.19 .84 1.69–4.83
Note: * 10ˆ3/uL, ** 10ˆ6/uL.
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24 hours the medium with virus was removed and
replaced by 2.5 ml RPMI, 15% FCS 1mM Na-pyru-
vate and 1 µg/ml cyclosporine A. This medium was
refreshed regularly according to standard procedures.
All samples were handled in the central laboratory
in Leiden where labeling of samples and distribution
of samples is centralized. The samples obtain a label
with double coding: one code represents the individ-
ual according to the twin register ID (code of family
and position in the family, e.g., father, mother, sister
or twin); the other code is sequential and is used to
identify the storage position of the sample. The differ-
ent types of samples are identified by the specific tube
or specific cap of the tube or storage box. Labeled
isolated samples of DNA are transported to
Amsterdam for storage. Labeled cryo-tubes with lym-
phocytes are sent for storage in liquid nitrogen to
Amsterdam. Tubes challenged for gene expression are
labeled in addition as A (basal control) and B (chal-
lenged) and stored in PAX tubes sequentially in
separate boxes in Leiden. Urine is stored in 15 ml
tubes sequentially in separate boxes in Leiden. Plasma
samples from EDTA blood (purple cap), from heparin
blood (green cap), from CTAD blood (blue cap) were
stored in boxes containing material from 4 partici-
pants in sequential order. The content from each box
and the position from each box in trays and the posi-
tion of each tray in a freezer cache is recorded in an
Excel file.
Zygosity Testing
Twins born to mothers recruited for the study included
22 opposite sex (OS) twin pairs and 24 same-sex (SS)
twin pairs. DNA typing from buccal swabs determined
information on zygosity of 24 SS twins (Meulenbelt et
al., 1995). OS twin pairs were not typed. Zygosity pack-
ages were given to the mothers of the twins during the
home visit. One SS twin pair was not typed for zygosity
because the mother of the twins was missed for blood
collection during this pilot study. This twin pair and
their mother will participate in the follow-up study.
Participants returned the packages by mail. Zygosity
testing was performed essentially as described (Rietveld
et al., 2000).
Results
Participants
Twenty-three of the 24 MODZT participated in the
pilot study. During the telephone interview, one of the
MODZT was excluded, because she did not meet the
criteria of having a sister with DZ twins. A total of 96
individuals agreed to participate. Eleven participants
were not bled (three MODZT, seven parents, one sister).
We missed three MODZT who had the third day of
their natural cycle at the same time as other partici-
pants, due to the large distances between their homes.
The parents of the mothers we missed will be visited for
blood collection at the same time as their daughters.
Three parents of the MODZT were not bled due to
health problems. One sister of a MODZT lived in
Canada and was therefore not bled. These four partici-
pants were asked to participate in DNA collection via
buccal swabs. One participant agreed and returned the
packages by mail.
In 10 families, two sisters with twins and their
parents were bled. In eight families only one of the
parents of the ASPs participated (all women), in two of
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Figure 1
Overview of blood collection and handling, for EDTA, heparin, citrate, and urine tubes.
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them additional siblings participated. In five families
both parents were deceased; we therefore asked siblings
of the ASPs to participate. A total of 18 additional sib-
lings (11 male and seven female) participated. In a few
informative and interesting families, other family
members were also asked to participate (e.g., grandpar-
ents and offspring of the MODZT who had also given
birth to DZ twins, see Figure 2).
The mean age of the proband was 44 years (range
28 to 70 years, Table 2) and the mean age of the sister
with twins was 46 years (range 25 to 74 years, Table 2).
Fourteen women had a natural cycle, 10 used oral con-
traceptives, 16 were in menopause, and six had had a
hysterectomy. Of the proband mothers 39% had a
natural cycle; two of them also had a sister with a
natural cycle.
Interview
All MODZT (n = 46) were interviewed by telephone.
The average interview time was between 20 and 30
minutes. Table 3 gives an overview of the characteristics
of the MODZT obtained from the telephone interview. 
Before determination of zygosity by DNA typing
from buccal swabs, questions regarding similarity of
the twins and experiences mistaking one for another
were asked together with the mothers’ judgment on
the zygosity of the twins. Eighteen of the 24 SS twin
pairs were judged by the mother as DZ. Five were
judged as probably DZ and one SS twin pair was
judged as probably MZ. 
The mean age of the twins of the interviewed
mothers was 14.5 years. The youngest twin was eight
Figure 2
Pedigree of a participating family.
Participating family members are shown with black circles.
Table 2
Mean Age of Proband Mothers and Participating Family Members and Number of Women with Natural Menstrual Cycle, Menopause, Oral
Contraceptive (OC) Use or Other.
Relative N Mean age Range Cycle
Natural Menopause OC Other  
Proband 23 44 28–70 9 7 5 2
Sister with twin 23 46 25–74 5 9 5 4
Sisters 7 65 59–74
Brothers 11 49 37–65
Mother 17 69 50–80
Father 10 68 54–78
Grandmother with twin 1 80
Grandfather 1 82
Daughter with twin 1 41
Son with twin 1 43
Total 96
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months old and the oldest nearly 40. The twin mothers
gave birth to between two and seven children (mean
3.3). None of the pregnancies was assisted by IVF or a
similar treatment. Clomiphene citrate (Clomid) was
used to assist a pregnancy in one twin mother, she was
one of a sister pair, but not excluded for the pilot study.
Twelve MODZT reported that they had female
family members with fertility problems (seven first-
degree family members and five second degree). None
of the mothers reported current medical problems. 
Transport and Logistics
All participants (N = 85) were visited for blood collec-
tion within a period of two months in Dutch
wintertime. The average traveling distance was 445 kilo-
meters per day and the average time between collection
of the samples and arrival in the laboratory was four
hours. We collected blood on the second, third or fourth
day of the menstrual cycle in 11 of the 14 women with a
natural cycle. We missed 3 women with a natural cycle
due to the broad dispersion of these mothers’ homes.
Participants were awake on average 1.4 hours before
the blood collection and they got out of bed between
5.30 a.m. and 8.55 a.m. Two participants were visited
before 7.00 a.m., before they went to work, and in four
participants we collected blood after 10.00 a.m. (but
before 11.00 a.m.) due to traffic jams. 
Blood Sampling
Before blood collection participants were asked the fol-
lowing questions. How is your current physical
condition? When was the last time you were ill (fever)?
What did you have for breakfast this morning, and did
you smoke this morning? We also assessed height and
weight. Five of the 85 participants reported that they
smoked before blood collection, and seven participants
reported not to have fasted.
Sixty-two participants reported that their physical
condition was good. Ten participants had a cold, 11
said they did not feel well (no fever) and two were really
ill (fever). C-Reactive protein (CRP) was measured as an
inflammatory marker in 73 participants. Figure 3 shows
the difference in mean CRP levels and reported physical
health, divided in two categories, normal health and dis-
comfort/illness. Of the 53 individuals reporting normal
health (score 1), only one person showed an increased
CRP level above 10 mg/l. Among persons reporting
some kind of discomfort or illness (score 2–4), 6 of the
20 participants showed a CRP level above10 mg/l. We
concluded that the questionnaire is mainly effective in
excluding acute phase reactions.
Evaluation of the platelet product beta-Thrombo-
globulin in citrated plasma revealed a value generally
above 150 IU/ml which is well above the expected 50
IU/ml and indicative of release of platelet products or
activation of platelets during transport and handling
(Kluft & Meijer, 1996). This precludes assay of some
haemostatic variables including PAI-1. To reduce this
effect in the future we will use CTAD anticoagulant
mixture, which exerts platelet stabilization (Kluft et
al., 1996).
Discussion
This pilot study has shown that, in the Netherlands, it
is feasible to collect blood and urine samples for
research purposes by making home visits to partici-
pants. We collected samples in nuclear families in the
morning after overnight fasting. After the home visit,
blood samples were immediately transported by car to
the laboratory. Women with a natural cycle were
visited on days two to four of their menstrual cycle and
women on oral contraceptives were visited during their
pill-free week. In this pilot study both the proband
mother and her sister were interviewed; in future
research all mothers of DZ twins will participate in the
telephone interview. 
Lymphocytes and RNA can be extracted with suf-
ficient yield and quality. For lymphocytes blood was
frozen at –80˚C during transport and then transferred
to liquid nitrogen for long-term storage. For RNA
blood was frozen at –80˚C and for a maximum of one
Table 3
Interview: Characteristics of Mothers of Dizygotic Twins (Obtained From the Telephone Interview)
N Mean SD Range
Age of mother: conception of twins 46 30.29 5.02 19–40
Age of mother: conception first child 46 26.28 4.91 14–39
Parity 46 3.33 1.19 2–7
Birth weight MODZT(gram) 38 3544 553.44 2500–5000
Height (cm) 46 171.33 6.56 152–185
Weight (current) 46 69.48 11.96 55–104
Minimum weight since 18 years old (kg) 46 59.20 6.71 45–78
Maximum weight since 18 years old (kg) 46 74.70 14.07 55–118
Weight during twin pregnancy 42 82.38 14.00 65–119
BMI (current) 46 23.71 4.14 17.9–35.6
Menstrual cycle (days) 35 25.5 3.32 19–30 
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month. RNA isolated from whole blood showed no
degradation of transcripts and it should be feasible to
perform gene-expression profiling studies with these
samples. The effects of prolonged storage (> 1 month)
on the amount of extracted RNA in polyethylene
aliquots are currently not known (see accompanying
paper, Spijker et al., 2004). In future research, we
may also challenge blood cells with immune systems
related lipopolysaccharide (LPS), since greater shifts
in gene-expression were observed during our pilot
study than after a dexamethasone challenge.
To obtain representative plasma variables, the
materials have to be stable for all individuals. We per-
formed our pilot in the winter period with a
significant number of flu cases in the Netherlands. We
observed an increased CRP > 10 mg/l in 7 individuals
raising the question whether some plasma variables
for these individuals are in a stable phase. The pres-
ence of high CRP indicates an acute phase reaction,
which may influence multiple quantitative traits and
affect the analysis. We observed that a questionnaire
is insufficient to predict high CRP, but excellent in
predicting CRP < 10 mg/l. In future, we have to
decide whether we will exclude cases with CRP > 10
mg/l or resample. The number of high values is
expected to be less in other periods of the year. 
In future research we will modify the sampling of
citrate tubes, by using CTAD tubes in an attempt to
stabilize the platelets better. In a preliminary study
with lithium heparin we observed that an interaction
with platelets occurs that dictates we first prepare
platelet-rich plasma and separate white cells from
platelets. This is not required for Natrium heparin
and would reduce the complexity of the procedures.
However, the lymphocyte harvest is better with
lithium heparin.
This study focused on families with affected sister
pairs (both sisters are mothers of DZ twins). It is a
pilot project for a larger study which aims to localize
and identify the genes causing variation in human DZ
twinning. Families from the Netherlands, Australia
and New Zealand participate in the study. Outside
the Netherlands participants are bled by their local
general practitioner and the samples are returned with
courier service to the Queensland Institute of Medical
Research. This procedure is an efficient and cheap
way of collecting DNA samples, but limited, when
blood samples need special handling after collecting
for RNA, lymphocytes and other blood parameters.
Another advantage of our approach is that transport
and blood handling, with a special team of motivated
trained nurses and analysts will minimize error and
ensure high quality of the blood samples. 
Of the 96 participants, 85 were bled. We could not
visit 11 participants, because distances between these
participants’ homes were too great to be feasible to
cover in one day. This was a relatively small pilot
group and we do not expect these logistic problems
with larger study designs. Home visits for blood and
urine collection resulted in high response rates and
cooperation. We expect that cooperation and response
rates will decline when participants have to be active in
providing blood samples (e.g., leaving their homes),
especially when participants are older (e.g., the parents
of the affected sister pairs). We will therefore use this
sample protocol in studies of other complex traits. The
protocol is currently implemented in the genetic study
of migraine, cardiovascular disease of attention and
memory, and of depression. These projects, including
the twinning study, will approach twin families regis-
tered with Netherlands Twin Register. Initially we will
invite 8000 participants. In this feasibility study, we
focused on twinning because it presented the most
complex logistics. The nationwide standardized blood
sampling and laboratory organization makes it possi-
ble to create a large, informative biobank.
In combination with the advances in molecular
technologies, such a biobank will help to broaden the
knowledge of the endocrinology and of the genes
involved in human DZ twinning and other complex
traits. In the study of DZ twinning hormone concen-
trations of, for example, LH, FSH, inhibin A and B
will be determined so that genome scans can be con-
ducted for linkage with endocrine parameters.
Likewise, once the genome-wide markers become
available, other parameters, which have been assessed
during the interview and home visit (e.g., height and
weight) and in plasma (e.g., lipids and apolipopro-
teins) can be used for sib-pair based linkage analyses.
In conclusion, the pilot study showed that nation-
wide sample collection is feasible in Dutch families
with two or more sisters who have given birth to
spontaneous dizygotic twins. Large-scale blood and
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Reported physical condition and CRP-level (N = 85).
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urine sample collection for this project will be com-
bined with similar sample collection in several other
linkage projects and will start in the fall of 2004. 
In July 2004, we started recruiting families for the
proposed DZ twinning study. Of the families
approached around 70% agreed to participate.
Sample collection, transport, blood handling and lab-
oratory organization will be based and standardized
on the results from this pilot study. 
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